Independent Survey Conducted on Treatment Challenges Related to "Mesotherapy" and Interest in Non-Invasive Transdermal Delivery Technology | Verification of Awareness of EPM-Equipped Devices Such as Derma Smart neo
MEDLAC Instrument and Consulting Inc. announced the results of an independent survey on the challenges of "mesotherapy" in Japanese medical settings and doctors' interest in non-invasive transdermal delivery technology. The survey also verified the awareness of EPM-equipped devices based on technical information from a Taiwanese corporation, contributing to future transparency of information on overseas medical devices.
📋 Article Processing Timeline
- 📰 Published: April 25, 2026 at 03:00
- 🔍 Collected: April 24, 2026 at 18:31
- 🤖 AI Analyzed: April 24, 2026 at 19:23 (52 min after Collected)
※This release provides an overview of the results of a survey independently conducted by our company.
※This is not intended to recommend specific products, procedures, treatments, adoption decisions, or usage.
※The results of this survey are based on information independently collected and analyzed by our company and do not guarantee specific efficacy, effectiveness, or safety in Japan.
※For individual adoption and usage decisions, please confirm the latest public information, relevant laws and regulations, appropriate materials from device providers, and other necessary information, and make your own judgment.
MEDLAC Instrument and Consulting Inc. (Headquarters: Fukuoka City, Fukuoka Prefecture; Representative Director: Hideki Ogawa) announces the results of an independent survey conducted to understand the recognition of challenges associated with "mesotherapy" procedures in domestic medical settings and the level of interest among doctors in non-invasive transdermal delivery technology.
Background of the Survey
In recent years, "mesotherapy" has become widely known in the medical field as a procedure for introducing active ingredients such as hyaluronic acid and vitamins into the skin.
However, because mesotherapy is an invasive procedure using injection needles, there are patient concerns regarding pain during the procedure and post-procedure downtime (redness, bruising, etc.). Additionally, the need for anesthesia can sometimes affect procedure time and clinic operational efficiency.
Amidst this situation, overseas manufacturers are advancing technological development in "non-invasive transdermal delivery devices" utilizing electroporation technology, and interest in such alternative technologies is growing in domestic medical settings.
As a provider of information on overseas medical devices, our company conducted this survey to understand what information needs and awareness of challenges medical professionals in Japan have regarding these technological trends.
Overview of Survey Results
This survey verified and analyzed the following three items:
① Interview on challenges related to existing transdermal delivery procedures, including mesotherapy
We conducted face-to-face interviews with doctors at domestic clinics regarding operational challenges (necessity of anesthesia, post-procedure downtime, uniformity of treatment, etc.) related to currently popular transdermal delivery procedures such as mesotherapy.
As a result, responses indicating recognition of challenges from multiple perspectives regarding the operation of transdermal delivery procedures were obtained.
② Survey on information needs for non-invasive transdermal delivery technology
We conducted a questionnaire survey on the information needs of domestic doctors and the suitability for the Japanese market regarding non-invasive transdermal delivery technology (EPM-equipped devices, etc.) with manufacturing data disclosed by a Taiwanese corporation.
As a result, data on the trend of interest in information on non-invasive transdermal delivery technology and its suitability for the Japanese market was obtained.
③ Interview on awareness of technical specifications of EPM-equipped devices (Derma Smart neo, etc.)
Based on manufacturing data disclosed from Taiwan, we conducted interviews with domestic doctors regarding their name recognition and understanding of technical specifications (multi-polar electrode method, compatibility with two types of microchips for skin and scalp, etc.) of transdermal delivery devices equipped with "EPM Therapy," which combines electroporation technology and special microchips (such as Derma Smart neo).
As a result, data on the awareness of the technical specifications of EPM-equipped devices was obtained.
Future Outlook
Since its establishment in 2019, our company has continuously interviewed domestic doctors about their needs regarding overseas medical devices.
This survey is part of that accumulation, initiated by a survey request from a Taiwanese corporation regarding their device, and involved collecting and analyzing doctors' opinions on the suitability of the transdermal delivery field for the Japanese market.
For detailed analysis results of each survey item, please contact us.
Our company will continue to work towards improving the transparency of information regarding overseas medical devices through the accumulation and publication of objective data.
Survey Outline
Item: Content
Survey Period: January 15, 2025 - March 31, 2026
Survey Organization (Survey Body): MEDLAC Instrument and Consulting Inc. (MEDLAC, Inc.) Research and Development Department
Survey Target: Doctors and clinic directors at domestic clinics who have previously used our company's overseas medical device provision support services
Valid Responses (Sample Responses): 32 experienced doctors (number of doctors actually interviewed or surveyed)
Survey Method:
① Challenge Interview: Face-to-face interviews on operational challenges in existing transdermal delivery procedures, including mesotherapy.
② Information Needs Survey: Questionnaire on information needs for non-invasive transdermal delivery technology with manufacturing data disclosed by a Taiwanese corporation, and its suitability for the Japanese market.
③ Awareness Survey: Interviews on name recognition and understanding of technical specifications of EPM-equipped devices based on manufacturing data disclosed from Taiwan.
※This is not intended to recommend specific products, procedures, treatments, adoption decisions, or usage.
※The results of this survey are based on information independently collected and analyzed by our company and do not guarantee specific efficacy, effectiveness, or safety in Japan.
※For individual adoption and usage decisions, please confirm the latest public information, relevant laws and regulations, appropriate materials from device providers, and other necessary information, and make your own judgment.
MEDLAC Instrument and Consulting Inc. (Headquarters: Fukuoka City, Fukuoka Prefecture; Representative Director: Hideki Ogawa) announces the results of an independent survey conducted to understand the recognition of challenges associated with "mesotherapy" procedures in domestic medical settings and the level of interest among doctors in non-invasive transdermal delivery technology.
Background of the Survey
In recent years, "mesotherapy" has become widely known in the medical field as a procedure for introducing active ingredients such as hyaluronic acid and vitamins into the skin.
However, because mesotherapy is an invasive procedure using injection needles, there are patient concerns regarding pain during the procedure and post-procedure downtime (redness, bruising, etc.). Additionally, the need for anesthesia can sometimes affect procedure time and clinic operational efficiency.
Amidst this situation, overseas manufacturers are advancing technological development in "non-invasive transdermal delivery devices" utilizing electroporation technology, and interest in such alternative technologies is growing in domestic medical settings.
As a provider of information on overseas medical devices, our company conducted this survey to understand what information needs and awareness of challenges medical professionals in Japan have regarding these technological trends.
Overview of Survey Results
This survey verified and analyzed the following three items:
① Interview on challenges related to existing transdermal delivery procedures, including mesotherapy
We conducted face-to-face interviews with doctors at domestic clinics regarding operational challenges (necessity of anesthesia, post-procedure downtime, uniformity of treatment, etc.) related to currently popular transdermal delivery procedures such as mesotherapy.
As a result, responses indicating recognition of challenges from multiple perspectives regarding the operation of transdermal delivery procedures were obtained.
② Survey on information needs for non-invasive transdermal delivery technology
We conducted a questionnaire survey on the information needs of domestic doctors and the suitability for the Japanese market regarding non-invasive transdermal delivery technology (EPM-equipped devices, etc.) with manufacturing data disclosed by a Taiwanese corporation.
As a result, data on the trend of interest in information on non-invasive transdermal delivery technology and its suitability for the Japanese market was obtained.
③ Interview on awareness of technical specifications of EPM-equipped devices (Derma Smart neo, etc.)
Based on manufacturing data disclosed from Taiwan, we conducted interviews with domestic doctors regarding their name recognition and understanding of technical specifications (multi-polar electrode method, compatibility with two types of microchips for skin and scalp, etc.) of transdermal delivery devices equipped with "EPM Therapy," which combines electroporation technology and special microchips (such as Derma Smart neo).
As a result, data on the awareness of the technical specifications of EPM-equipped devices was obtained.
Future Outlook
Since its establishment in 2019, our company has continuously interviewed domestic doctors about their needs regarding overseas medical devices.
This survey is part of that accumulation, initiated by a survey request from a Taiwanese corporation regarding their device, and involved collecting and analyzing doctors' opinions on the suitability of the transdermal delivery field for the Japanese market.
For detailed analysis results of each survey item, please contact us.
Our company will continue to work towards improving the transparency of information regarding overseas medical devices through the accumulation and publication of objective data.
Survey Outline
Item: Content
Survey Period: January 15, 2025 - March 31, 2026
Survey Organization (Survey Body): MEDLAC Instrument and Consulting Inc. (MEDLAC, Inc.) Research and Development Department
Survey Target: Doctors and clinic directors at domestic clinics who have previously used our company's overseas medical device provision support services
Valid Responses (Sample Responses): 32 experienced doctors (number of doctors actually interviewed or surveyed)
Survey Method:
① Challenge Interview: Face-to-face interviews on operational challenges in existing transdermal delivery procedures, including mesotherapy.
② Information Needs Survey: Questionnaire on information needs for non-invasive transdermal delivery technology with manufacturing data disclosed by a Taiwanese corporation, and its suitability for the Japanese market.
③ Awareness Survey: Interviews on name recognition and understanding of technical specifications of EPM-equipped devices based on manufacturing data disclosed from Taiwan.